Ann E. Kingston

3.2k total citations
51 papers, 2.7k citations indexed

About

Ann E. Kingston is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Ann E. Kingston has authored 51 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Ann E. Kingston's work include Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Ann E. Kingston is often cited by papers focused on Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (12 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Ann E. Kingston collaborates with scholars based in United States, United Kingdom and Italy. Ann E. Kingston's co-authors include David Lodge, Darryle D. Schoepp, Rebecca A. Wright, James A. Monn, M J Colston, Stephen M. Fitzjohn, Bryan G. Johnson, Kristján R. Jessen, Graham L. Collingridge and Rhona Mirsky and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Comparative Neurology.

In The Last Decade

Ann E. Kingston

50 papers receiving 2.6k citations

Peers

Countries citing papers authored by Ann E. Kingston

Since Specialization

Citations

This map shows the geographic impact of Ann E. Kingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Kingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Kingston more than expected).

Fields of papers citing papers by Ann E. Kingston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Kingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Kingston. The network helps show where Ann E. Kingston may publish in the future.

Co-authorship network of co-authors of Ann E. Kingston

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Kingston. A scholar is included among the top collaborators of Ann E. Kingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Kingston. Ann E. Kingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Forest school INterventions for Children’s Health: a feasibility cluster randomised controlled trial to compare Forest School versus usual indoor classroom-based curriculum activity with KS2 children: the FINCH protocol 2025 ·NIHR Open Research ·(unknown), (unknown), Jodi Pervin, Sarah Blower, (unknown), Bernadka Dubicka, (unknown), Susan Griffin, Catherine Hewitt, (unknown), (unknown), Ann E. Kingston, (unknown), (unknown), (unknown), Margaret A. Palmer, Piran C. L. White, Peter Coventry	0
2	Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide 2009 ·Brain Research ·(unknown), Viktor Lakics, Hyoung‐gon Lee, Lisa M. Broad, Theresa A. Day, (unknown), Mark A. Smith, Michael J. O’Neill, Ann E. Kingston	75
3	Development of Homogeneous 384-Well High-Throughput Screening Assays for Aβ1-40 and Aβ1-42 Using AlphaScreen™ Technology 2008 ·SLAS DISCOVERY ·Philip Szekeres, (unknown), Theresa A. Day, Ann E. Kingston, Eric Karran	31
4	Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist 2005 ·Neuropharmacology ·Harlan E. Shannon, Steven Peters, Ann E. Kingston	30
5	Functional Metabotropic Glutamate Receptors on Nuclei from Brain and Primary Cultured Striatal Neurons 2005 ·Journal of Biological Chemistry ·Yuh‐Jiin I. Jong, Vikas Kumar, Ann E. Kingston, Carmelo Romano, Karen L. O’Malley	94
6	Expression of metabotropic glutamate receptors in rat meningeal and brain microvasculature and choroid plexus 2003 ·The Journal of Comparative Neurology ·Samantha Gillard, John A. Tzaferis, Ho‐Ching Tiffany Tsui, Ann E. Kingston	34
7	Systemic pre‐treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo 2002 ·British Journal of Pharmacology ·(unknown), Ann E. Kingston, David Lodge, James A. Monn, P.M. Headley	39
8	(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord 2001 ·Neuropharmacology ·Nicola Thomas, Rebecca A. Wright, Patrick A. Howson, Ann E. Kingston, Darryle D. Schoepp, David E. Jane	118
9	A novel, competitive mGlu₅ receptor antagonist (LY344545) blocks DHPG‐induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices 2000 ·British Journal of Pharmacology ·Andrew J. Doherty, Mary J. Palmer, Z A Bortolotto, (unknown), Ann E. Kingston, Paul L. Ornstein, D D Schoepp, David Lodge, G.L. Collingridge	67
10	Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo 1999 ·Neuropharmacology ·T.E. Salt, J.P. Turner, Ann E. Kingston	25
11	Evaluation of the activity of a novel metabotropic glutamate receptor antagonist (±)-2-amino-2-(3-cis and trans-carboxycyclobutyl-3-(9-thioxanthyl)propionic acid) in the in vitro neonatal spinal cord and in an in vivo pain model 1999 ·Neuroscience ·(unknown), (unknown), Emanuele Sher, Barry P. Clark, Mary Jeanne Kallman, Rebecca A. Wright, Bryan G. Johnson, Darryle D. Schoepp, Ann E. Kingston	23
12	Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors 1999 ·Neuropharmacology ·Valeria Bruno, Giuseppe Battaglia, Ann E. Kingston, (unknown), Maria Vincenza Catania, Renato Di Grezia, Ferdinando Nicoletti	116
13	DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists 1999 ·Neuropharmacology ·Stephen M. Fitzjohn, Ann E. Kingston, David Lodge, Graham L. Collingridge	145
14	Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795 1999 ·European Journal of Pharmacology ·Ann E. Kingston, Michael J. O’Neill, (unknown), Kelly R. Bales, James A. Monn, Darryle D. Schoepp	85
15	Synthesis and metabotropic glutamate receptor antagonist activity of N1-substituted analogs of 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic acid 1998 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. Valli, Darryle D. Schoepp, Rebecca A. Wright, Bryan G. Johnson, Ann E. Kingston, Rosemarie Tomlinson, James A. Monn	11
16	Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell lines 1998 ·Neuropharmacology ·Ann E. Kingston, (unknown), Non Evans, Bryan W. Clark, Rosemarie Tomlinson, J. Paul Burnett, Nancy G. Mayne, Sandra L. Cockerham, David Lodge	36
17	In Vitro and in Vivo Effects of Proteoglycan Fractions in Adjuvant Treated Rats 1993 ·Birkhäuser Basel eBooks ·Ann E. Kingston, Stephen Carney, C A Hicks, M. E. J. Billingham	1
18	Rat Schwann cells produce interleukin-1 1991 ·Journal of Neuroimmunology ·Kristín Bergsteinsdóttir, Ann E. Kingston, Rhona Mirsky, Kristján R. Jessen	78
19	Schwann cells co‐cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon‐γ pretreatment: synergistic effects of interferon‐γ and tumor necrosis factor on MHC class II induction 1989 ·European Journal of Immunology ·Ann E. Kingston, Kristín Bergsteinsdóttir, Kristján R. Jessen, (unknown), M. Joseph Colston, Rhona Mirsky	67
20	Immunological activity of a 14-kilodalton recombinant protein of Mycobacterium tuberculosis H37Rv 1987 ·Infection and Immunity ·Ann E. Kingston, Padmini Salgame, N Mitchison, M J Colston	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact